Predicting possible Alzheimer’s with nearly 100% accuracy

Latest articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

Most read

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Editor's picks

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

Click the globe for translations.

Researchers develop a deep learning-based method that can predict the possible onset of Alzheimer’s disease from brain images with an accuracy of over 99%.

Researchers from Kaunas University of Technology in Lithuania developed a deep learning-based method that can predict the possible onset of Alzheimer’s disease from brain images with an accuracy of over 99%. The method was developed while analysing functional MRI images obtained from 138 subjects and performed better in terms of accuracy, sensitivity and specificity than previously developed methods.

Longevity.Technology: According to World Health Organisation, Alzheimer’s disease is the most frequent cause of dementia, contributing to up to 70% of dementia cases [1]. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in years to come.

“Medical professionals all over the world attempt to raise awareness of an early Alzheimer’s diagnosis, which provides the affected with a better chance of benefiting from treatment. This was one of the most important issues for choosing a topic for Modupe Odusami, a PhD student from Nigeria,” says Rytis Maskeliūnas, a researcher at the Department of Multimedia Engineering, Faculty of Informatics, Kaunas University of Technology (KTU), Odusami’s PhD supervisor [2].

Image processing delegated to the machine

One of the possible Alzheimer’s first signs is mild cognitive impairment (MCI), which is the stage between the expected cognitive decline of normal aging and dementia. Based on the previous research, functional magnetic resonance imaging (fMRI) can be used to identify the regions in the brain which can be associated with the onset of Alzheimer’s disease, according to Maskeliūnas. The earliest stages of MCI often have almost no clear symptoms, but in quite a few cases can be detected by neuroimaging.

However, although theoretically possible, manual analysing of fMRI images attempting to identify the changes associated with Alzheimer’s not only requires specific knowledge but is also time-consuming – application of Deep learning and other AI methods can speed this up by a significant time margin. Finding MCI features does not necessarily mean the presence of illness, as it can also be a symptom of other related diseases, but it is more of an indicator and possible helper to steer toward an evaluation by a medical professional.

“Modern signal processing allows delegating the image processing to the machine, which can complete it faster and accurately enough. Of course, we don’t dare to suggest that a medical professional should ever rely on any algorithm 100%. Think of a machine as a robot capable of doing the most tedious task of sorting the data and searching for features. In this scenario, after the computer algorithm selects potentially affected cases, the specialist can look into them more closely, and at the end, everybody benefits as the diagnosis and the treatment reaches the patient much faster,” says Maskeliūnas, who supervised the team working on the model [2].

Making the most of the data

The deep learning-based model was developed as a fruitful collaboration of leading Lithuanian researchers in the Artificial Intelligence sector, using a modification of well-known fine-tuned ResNet 18 (residual neural network) to classify functional MRI images obtained from 138 subjects. The images fell into six different categories: from healthy through the spectre of mild cognitive impairment (MCI) to Alzheimer’s disease. In total, 51,443 and 27,310 images from The Alzheimer’s Disease Neuroimaging Initiative fMRI dataset were selected for training and validation.

The model was able to effectively find the MCI features in the given dataset, achieving the best classification accuracy of 99.99%, 99.95%, and 99.95% for early MCI vs AD, late MCI vs AD, and MCI vs early MCI, respectively.

Ovarian Longevity webinar

“Although this was not the first attempt to diagnose the early onset of Alzheimer’s from similar data, our main breakthrough is the accuracy of the algorithm. Obviously, such high numbers are not indicators of true real-life performance, but we’re working with medical institutions to get more data,” says Maskeliūnas [2].

According to him, the algorithm could be developed into software, which would analyse the collected data from vulnerable groups (those over 65, having a history of brain injury, high blood pressure, &c) and notify the medical personnel about the anomalies related to the early onset of Alzheimer’s.

“We need to make the most of data,” says Maskeliūnas, “that’s why our research group focuses on the European open science principle, so anyone can use our knowledge and develop it further. I believe that this principle contributes greatly to societal advancement [2].”

The chief researcher, whose main area is focusing on the application of modern methods of artificial intelligence on signal processing and multimodal interfaces, says that the above-described model can be integrated into a more complex system, analysing several different parameters, for example, also monitoring eye movements’ tracking, face reading, voice analysing, &c. Such technology could then be used for self-check and alert to seek professional advice if anything is causing concern.

“Technologies can make medicine more accessible and cheaper. Although they will never (or at least not soon) truly replace the medical professional, technologies can encourage seeking timely diagnosis and help,” says Maskeliūnas [2].

Small molecule can rejuvenate the Alzheimer’s brain – read more

Ovarian Longevity webinar

[1] https://www.who.int/news-room/fact-sheets/detail/dementia
[2] https://en.ktu.edu/news/algorithm-developed-by-lithuanian-researchers-can-predict-possible-alzheimers-with-nearly-100-per-cent-accuracy/

Image courtesy of Kaunas University of Technology

 

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...

Related articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Occuity raises over £2.5m for optical diabetes devices

UK MedTech firm Occuity successfully raises over £2.5m to deliver ophthalmic and optical diabetes devices and is now overfunding on Seedrs to accelerate development. DISCLOSURE:...

Eyes provide early view of Alzheimer’s risk

Protein deposits in the retina and brain appear to parallel possible neurodegeneration, an insight that might lead to easier, quicker detection. Amyloid plaques are protein...

Shifting gear: startup aims to de-risk rejuvenation therapy

Shift Bioscience raising funding to develop safe cellular reprogramming therapies for rejuvenation. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has been contracted by the...

Longevity industry “taking shape”

ARDD 2021 kicks off: sessions to cover longevity topics from AI and senolytics to mitochondria and stem cell rejuvenation. Following yesterday’s workshops, ARDD 2021 really...
Nutriop